APA (7th ed.) Citation

Lederer, A., Kessler, C. J., Bouzakri, N., Lozan, O., Wild, F., Rauschkolb-Olk, K. T., . . . Musholt, T. J. (2026). The Pitfalls of Calcitonin as a Tumor Marker: Real-Life Data of Patients with Elevated Basal Calcitonin Levels but Without Evidence of Medullary Thyroid Carcinoma. Journal of Clinical Medicine, 15(7), 2500. https://doi.org/10.3390/jcm15072500

Chicago Style (17th ed.) Citation

Lederer, Ann-Kathrin, Constantin-Leonard Jacob Kessler, Nabila Bouzakri, Oana Lozan, Florian Wild, Katharina Theresa Rauschkolb-Olk, Heidi Rossmann, Hauke Lang, and Thomas J. Musholt. "The Pitfalls of Calcitonin as a Tumor Marker: Real-Life Data of Patients with Elevated Basal Calcitonin Levels but Without Evidence of Medullary Thyroid Carcinoma." Journal of Clinical Medicine 15, no. 7 (2026): 2500. https://doi.org/10.3390/jcm15072500.

MLA (9th ed.) Citation

Lederer, Ann-Kathrin, et al. "The Pitfalls of Calcitonin as a Tumor Marker: Real-Life Data of Patients with Elevated Basal Calcitonin Levels but Without Evidence of Medullary Thyroid Carcinoma." Journal of Clinical Medicine, vol. 15, no. 7, 2026, p. 2500, https://doi.org/10.3390/jcm15072500.